 | |
- close
- close
|
THE PRAGMATIC CAPITALIST
Oct 19
Comment
A bullish call spread is sparking attention as one trader hopes to cash in for millions on a bullish bet on biotech:
Charts and Coffee Blog
Aug 12
Comment
I'm still trading light. I'm currently 13% invested.I added IBB long today. I currently have a negative delta, and I was looking to add some long exposure in case this is just a pullback. IBB offered a nice low risky entry today. The intersection...
Charts and Coffee Blog
Feb 4
Comment
IBB (Biotech) is getting interesting. I shorted a 2% position today at $72.50. I have a very tight stop just above $73. This is looking like an ascending triangle could be forming. If it breaks $73 on volume, I'll be reversing positions and...
Charts and Coffee Blog
Jan 11
Comment
Here are two ETFs that are often not discussed by more sophisticated traders. They tend to be discussed in the more mainstream "fundamental analysis" articles and generally don't provide enough pop to get traders excited. The biggest component of...
Suggest other news sources for this topic
Thank you for your suggestion
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
This article describes an exchange traded fund that tracks an index, commodity, currency, or varied basket of securites. View articles referencing this fund. |
TOP CONTRIBUTORS
iShares Nasdaq Biotechnology Index Fund (IBB)
Overview
The iShares Nasdaq Biotechnology Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of companies primarily engaged in the biotechnology industry, as represented by the NASDAQ Biotechnology Index®. [1]
Fund Information
- Fund Manager - Ishares
- Inception Date - 02/05/2001
- Exchange – NYSE Arca
- Index Ticker – IBB
- Intra-day NAV Ticker – IBB.IV
- Expense Ratio - 0.48%
Top Holdings
| Holdings | % of Portfolio |
| AMGEN INC | 10.55% |
| GILEAD SCIENCES INC | 8.73% |
| TEVA PHARMACEUTICAL-SP ADR | 7.89% |
| CELGENE CORP | 6.35% |
| VERTEX PHARMACEUTICALS INC | 4.10% |
| BIOGEN IDEC INC | 3.02% |
| GENZYME CORP | 3.00% |
| ALEXION PHARMACEUTICALS INC | 2.54% |
| Life Technologies Corp | 2.32% |
| MYLAN INC | 2.29% |
Holdings as of 05/11/2009
Other Bio-Technology ETFs
| ETF Name | Fund Manager | Expense Ratio |
| Biotech HOLDRS ETF (BBH) | Merrill Lynch, Pierce, Fenner & Smith HOLDRS | N/A |
| First Trust AMEX Biotechnology Index Fund (FBT) | First Trust Advisors L.P | 0.60% |
| Global Biotech Portfolio ETF (PBTQ) | Invesco PowerShares | 0.75% |
| iShares Nasdaq Biotechnology Index Fund (IBB) | ishares | 0.48% |
| Powershares Dynamic Biotechnology & Genome Portfolio ETF (PBE) | Invesco PowerShares | 0.60% |
| SPDR S&P Biotech ETF (XBI) | State Street Global Markets, LLC | 0.35% |
References
| ||||||
